Objective: To determine the efficacy of intranasal aqueous triamcinolone acetonide in treating the tympanometric signs and symptoms of eustachian tube dysfunction, such as otitis media with effusion and negative middle ear pressure.
Design: Randomized, placebo-controlled, double-blind prospective clinical trial.
Setting: Tertiary referral clinic.